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Recent findings and future perspectives of -omics studies on the bovine milk microbiota, 12 
focusing on its impact on animal health 13 
Summary 14 
The recent and significant progresses in culture-independent techniques, together with the parallel development 15 
of -omics technologies and data analysis capabilities, have led to a new perception of the milk microbiota as a 16 
complex microbial community with great diversity and multifaceted biological roles, living in an environment that 17 
was until recently believed to be sterile. In this review, we summarize and discuss the latest findings on the milk 18 
microbiota in dairy cows, with a focus on the role it plays in bovine physiology and health. 19 
Following an introduction on microbial communities and the importance of their study, we present an overview of 20 
the -omics methods currently available for their characterization, and outline the potential offered by a systems 21 
biology approach encompassing metatranscriptomics, metaproteomics, and metametabolomics. Then, we review 22 
the recent discoveries on the dairy cow milk microbiome enabled by the application of -omics approaches. 23 
Learning from studies in humans and in the mouse model, and after a description of the endogenous route 24 
hypothesis, we discuss the role of the milk microbiota on both the mother and the offspring physiology and health, 25 
and report how it can be changed by farming practices and during infection. In conclusion, we shortly outline the 26 
impact of the milk microbiota on quality of milk and of dairy products. 27 
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 28 
Microbial communities and the milk microbiota 29 
The complex living entities defined as microbial communities, or microbial consortia, have gained increasing 30 
interest in the recent years, and the evolution of advanced molecular methods has spurred a significant wave of 31 
studies dedicated to their detailed understanding. Learning from these studies, we have now become aware that 32 
animals host a wide diversity of microbial communities that have evolved with them as a result of complex and 33 
mutualistic interactions, and that play crucial roles in their biology and health status.
1,2
  The paradigm of a highly 34 
evolved, complex, and tightly host-interconnected microbial community is the gastrointestinal microbiota, 
3–6
  but 35 
in the recent years the microbial communities of diverse anatomical sites have been characterized, ranging from 36 
more obvious districts such as the skin and the genitourinary tract, to less obvious ones such as the airways, and 37 
including areas that were previously considered as absolutely devoid of microorganisms, such as the placenta and 38 
the fetus.
7,8
 Until recently, the mammary gland and the milk contained in it were also believed to be sterile,
9
 and 39 
microorganisms found in milk were thought to be the result of an external contamination. However, this belief has 40 
recently been challenged, as a result of the integration of culture-based methods with more sensitive molecular 41 
methods.
10
 42 
Due to its importance for animal health and its correlations with quality and safety of dairy productions, the 43 
interest in understanding the origin and composition of the milk microbiota has significantly grown in the last 44 
decade.
11
 As a result of the rapid evolution of meta-omics sciences, a wide range of approaches is now available 45 
for its detailed characterization, enabling to gather information ranging from its taxonomic composition, to its 46 
functional potential, to the molecules it produces as a result of its functioning (Figure 1). 47 
 48 
 49 
Figure 1. Outline of the approaches available for studying the milk microbiota. 50 
 51 
Approaches to understanding the milk microbiota: 16S metagenomics and shotgun metagenomics 52 
The characterization of the whole set of microbial genomes, the metagenome, might be based on target 53 
sequencing of the 16S rDNA or supported by shotgun, genome wide, sequencing. The former approach relies on a 54 
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combination of PCR amplification and sequencing of a 16S rRNA gene fragment (16S metagenomics).
12,13
  55 
Therefore, it allows the characterization of the bacterial component in the microbial community. The rRNA genes 56 
are the most conserved genes in all bacteria, yet they carry hypervariable regions, where sequences have diverged 57 
over evolutionary time. In 16S rDNA sequencing studies, a pair of so called “universal” primers is designed to bind 58 
to conserved regions and amplify variable regions that capture the taxonomic information. Sequencing of the 59 
amplified pool of 16S rDNA fragments enables the most accurate assignment of each read to its specific taxon. 60 
Then, the relative abundance of each taxon can be estimated.
14
 61 
However, amplicon-based metagenomics suffers several limitations, including the loss of diversity due to PCR 62 
biases,
15–18
 and variability in diversity estimates.
19
 For instance, different 16S rDNA variable loci have differential 63 
capacity in resolution of taxa, and the number of 16S rRNA gene copies in bacterial genomes varies quite 64 
considerably. in addition, amplicon sequencing gives information on the taxonomy of the community, but not on 65 
its biological functions.
19–21
 Although phylogenetic reconstruction may provide hints into this latter aspect,
22
 its 66 
accuracy is linked to the correct representation of the microbial diversity in the genome sequence databases and is 67 
hampered by the functional gene heterogeneity between strains of the same species due to horizontal gene 68 
transfer.
23
 69 
To extend the information captured by 16S metagenomics, shotgun metagenomics provides a further approach to 70 
study the non-culturable microbiota, offering a wider perspective on microbial diversity.
17
 In this case, instead of 71 
amplifying a specific target locus, the whole metagenomic DNA is extracted, reduced into fragments, and 72 
sequenced. This produces a great number of genomic sequences, that align to genomic locations in all the DNA 73 
genomes of the whole community, including DNA viruses and yeasts. As a result, it becomes possible to 74 
interrogate these data either by sampling taxonomically informative loci, such as the 16S rDNA, or by analyzing 75 
those sequences that provide information on the functional potential of the metagenome, that is, understand who 76 
is in the community, but also what the community is capable of doing. Interestingly, the metagenome of a complex 77 
microbial community (e.g. human feces) has been reported to be linearly correlated with the metatranscriptome, 78 
indicating that the measured potential and actual activity of the microbiota share many similarities.
24
 79 
Of course, this huge potential brings several challenges.
17,25–29
 The first and most obvious one is represented by the 80 
extreme complexity and dimension of the data generated. In addition, being the metagenome a collection of 81 
genomes highly diverse in abundance, less represented genomes may be only partially sequenced, and difficulties 82 
often arise in obtaining extended sequences assembly and alignment.
30
 The vast amount of data generated, then, 83 
needs to be interrogated in order to obtain meaningful results. This presents problems both in terms of 84 
computational power and of dedicated informatics software for analysis and interpretation of results. In addition, 85 
unwanted host DNA may be present, often in significant amounts, requiring the application of molecular and 86 
bioinformatic methods for its removal.
31–33
 A wide and constantly evolving range of bioinformatic tools for 87 
taxonomy and functional analysis is available in free software platforms, such as mothur, QIIME, and UniFrac for 88 
16S, MGRAST, Kraken, and MEGAN for metagenomics, and LEfSe for differential analysis. Statistical analysis can 89 
then be carried out in packages such as R, Metastats, or Primer-E.
17,29,34
 90 
As a final consideration, generating metagenomic data is relatively more expensive, although the rapid progresses 91 
in DNA sequencing technologies are improving this aspect. Several different platforms are available.
35
 92 
Pyrosequencing with the Roche/454 GS-FLX is a reliable system that provides long reads (500 bp), but newer NGS 93 
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platforms, such as Illumina’s HiSeq and MiSeq and Life Technologies’ Ion Torrent, have elevated sequencing 94 
potentials. In bacterial microbiota studies, the HiSeq can provide the highest data output with the lowest costs, but 95 
MiSeq is preferable when short turn-around times are desired.
36,37
 The Ion Torrent (Ion PGM™ Sequencer and Ion 96 
Proton™ Sequencer) is also a valid low-cost, scalable and high-throughput alternative, providing up to 400 bp 97 
sequence reads.
38
 To date, high-throughput sequencing has not been extensively applied to assess the ruminant 98 
milk microbiota, but that will likely change significantly in the years to come.
11,39–41
 99 
 100 
Beyond metagenomics: metatranscriptomic, metaproteomic, and metametabolomic methods 101 
As stated above, the genomic content of a microbial community gives insights about its functional potential, but 102 
no information can be inferred about the functional activities that the microbiota is actually accomplishing in a 103 
particular condition or time point. To reach this goal, additional -omics data should be collected from the microbial 104 
community by means of metatranscriptomics, metaproteomics and metametabolomics (Figure 1 and Table 1).
42
 105 
 106 
Table 1. Features of the -omics approaches available for studying microbial communities. 107 
Approach Target molecule(s)  Information provided Drawbacks 
16S metagenomics 16S rRNA gene (or its 
hypervariable regions) 
Taxonomic distribution Only bacteria are characterized 
Metagenomics Community DNA Taxonomic distribution and gene 
potential 
Issues with sequence annotation 
and costs 
Metatranscriptomics Community RNA 
(or mRNA) 
Taxonomic distribution and gene 
expression 
Issues with RNA stability and data 
analysis 
Metaproteomics Community proteins Taxonomic distribution and 
protein expression 
Issues with protein dynamic range 
and data analysis 
Metametabolomics Community metabolites/ 
organic compounds 
Metabolic fluxes No direct link between metabolite 
and microbial taxonomy 
 108 
 109 
Metatranscriptomics analyzes the RNA transcript pool expressed by a microbial community at a specific point in 110 
time,
43
 thus allowing a simultaneous investigation of the gene expression (mRNA) and abundance (rRNA) of 111 
microorganisms.
44
 When 16S rDNA data are already available or not necessary, several strategies can be applied to 112 
enrich for prokaryotic mRNA molecules and reduce the rRNA fraction of metatranscriptomes,
45
 such as selective 113 
nuclease degradation of rRNA,
46
 rRNA depletion by capture with commercial kits,
47
 and polyadenylation and 114 
enrichment of mRNA.
48
 After extraction, RNA is subjected to reverse transcription to cDNA, and cDNAs are 115 
analyzed by high-throughput sequencing technologies (RNA-seq).
49,50
 Quality assessment and decontamination 116 
from host/rRNA sequences can be performed using standard metagenomics tools. Sample preparation issues due 117 
to the low stability of RNA and bioinformatic issues related to sequence reconstruction, annotation and statistical 118 
analysis can be considered as the main challenging aspects in a metatranscriptomic investigation.
51
 119 
Metaproteomics encompasses the large-scale study of the whole protein complement of a microbiota, providing a 120 
direct measure of the functional activity of a microbial community.
13,43
 (Meta)proteomic approaches also enable 121 
the analysis of splicing variants and co- and post-translational modifications, as well as the detection of protein-122 
protein interactions and protein complexes.
52
 The analytical requirements for metaproteome characterization 123 
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include high sensitivity and broad dynamic range in peptide identification.
53
 In view of this, coupling effective liquid 124 
chromatography (LC) separation systems with high-resolution mass spectrometers (MS) represents the state-of-125 
the-art technique for metaproteomics.
54
 In a typical metaproteomic experiment, the extracted proteins are 126 
therefore digested with proteolytic enzyme(s) to generate a complex peptide mixture, which is eventually analyzed 127 
by LC-MS. The presence of contaminating proteins (e.g. from the host), the huge dynamic range in protein 128 
abundance, and - even more importantly - the bioinformatic analysis issues (especially related to construction and 129 
annotation of sequence databases for peptide identification) are the most difficult tasks in metaproteomic 130 
studies.
55,56
 Notably, the availability of (meta)genomic sequences from the community being studied is vital for 131 
efficient protein identification and annotation.
57–59
 132 
Metametabolomics refers to the systematic analysis of the metabolite complement produced by microbial 133 
communities. Metabolites are typically in a state of flux, which implies that their abundance varies as a function of 134 
time within the ecosystem.
60
 The most common analytical techniques used to characterize a microbial 135 
metabolome are MS and proton nuclear magnetic resonance (NMR), each one with its respective advantages and 136 
disadvantages: NMR is a non-destructive, non-selective and cost-effective approach, while MS offers better 137 
sensitivity and, if coupled to separation techniques (as LC or gas chromatography), is capable to detect a broader 138 
range of molecules.
61,62
 Specific issues concerning metametabolomic analysis are due to the non-uniformity of the 139 
molecules to be profiled (spanning a broad range in hydrophobicity and molecular weight), as well as to the 140 
impossibility to directly link the particular metabolite detected to a specific microbial taxonomy.
51,63
 141 
The application of a systems biology approach - comprising metatranscriptomics, metaproteomics and 142 
metametabolomics – to the study of the milk microbiota in the years to come is expected to provide a much wider 143 
and sharper picture of the functional activity of milk microbial communities, compared to the information that one 144 
would infer from DNA sequence alone. Each -omics technology provides a unique perspective, and, by integrating 145 
these large-scale datasets, scientists can investigate microbial community dynamics and interactions at an 146 
unprecedented level (Table 1).
64
 147 
 148 
The healthy milk microbiota 149 
Milk is a complex, species-specific biological fluid aimed to satisfy the nutritional requirements of the mammalian 150 
offspring, but it does also exert numerous functional roles along offspring development.
2,65–67
 The biological 151 
actions of milk are due to presence of immune cells and of an assortment of active molecules, including sugars, 152 
nucleotides, lipids, immunoglobulins, antimicrobial proteins, cytokines, and other immuno-modulatory 153 
factors.
66,68–71
 In addition, milk contains a complex and varied community of bacteria, with an abundance 154 
estimated in approximately 10
3
-10
4
 colony-forming units per milliliter in human milk.
72
 155 
The human milk microbiota has been the subject of different studies in the recent years, aimed to understand its 156 
role in physiology and health of both the nursing mother and her infant.
65,66
 On the other hand, most studies on 157 
the dairy ruminant microbiota have been carried out with a focus on how the microbial flora of milk changes when 158 
it becomes a food product, either for direct consumption or for transformation into dairy products. That is, by 159 
considering microbial ecology of raw milk, rather than how the milk microbiota behaves in the context of animal 160 
health and physiology.
11
 To date, only few studies have been carried out in cows with this purpose. Kuehn et al. 161 
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used pyrosequencing of bacterial 16S rRNA genes to investigate bacterial DNA diversity in 10 mastitic, culture 162 
negative, milk samples.
73
 In this work, the microbiota of milk samples obtained from healthy quarters from the 163 
same cows was also described for comparison purposes. The authors were able to show significant differences 164 
among the microbial profiles of healthy milk samples. The most abundant genera were: Ralstonia, Pseudomonas, 165 
Sphingomonas, Stenotrophomonas, Psychrobacter, Bradyrhizobium, Corynebacterium, Pelomonas, and 166 
Staphylococcus. Abundances of Pseudomonas, Psychrobacter, and Ralstonia were significantly higher in healthy 167 
samples comparing to the mastitic ones. In a more recently published study, Oikonomou et al. described in detail 168 
the microbial diversity of 144 bovine milk samples derived from clinically unaffected quarters across a range of 169 
somatic cell count values.
74
 Four bacterial genera were present in all the samples obtained from healthy quarters 170 
(Faecalibacterium, unclassified Lachnospiraceae, Propionibacterium and Aeribacillus) and could be considered part 171 
of a healthy milk core microbiota. Other genera found to be prevalent in most of the milk samples with very low 172 
somatic cell counts were: Bacteroides, Staphylococcus, Streptococcus, Anaerococcus, Lactobacillus, 173 
Porphyromonas, Comamonas, Fusobacterium and Enterococcus (Figure 2). Certain bacterial genera (e.g. 174 
Lactobacillus, Paenibacillus) were associated with healthier udder quarters. 175 
 176 
 177 
Figure 2. Distribution of the twenty most prevalent bacterial genera found in 50 healthy quarter milk samples with 178 
less than 20,000 cells/mL.
74
 179 
 180 
Zhang et al. described the effects of different dairy cattle diets (high concentrate versus low concentrate diet) on 181 
milk microbial communities using pyrosequencing of the 16s rRNA genes.
75
 Despite the small number of animals 182 
enrolled in their study (n=4) the authors were able to suggest diet associated differences in milk microbial 183 
communities. In the work of Falentin et al.,
76
 milk from healthy quarters was associated to a high proportion of the 184 
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Clostridia class, the Bacteroidetes phylum and the Bifidobacteriales order. Table 2 summarizes the current findings 185 
on composition of the healthy cow milk microbiota. 186 
 187 
Table 2. Composition of the healthy cow milk microbiota. 188 
Study Most prevalent genera 
Kuehn et al.
73
 Ralstonia, Pseudomonas, Sphingomonas, Stenotrophomonas, Psychrobacter, Bradyrhizobium, 
Corynebacterium, Pelomonas, Staphylococcus 
Oikonomou et al.
77
 Propionibacterium, Aeribacillus, unclassified Lachnospiraceae, Faecalibacterium, Bacteroides, 
unclassified Clostridiales, Staphylococcus, Streptococcus, Anaerococcus, Unclassified 
Xanthomonadaceae, unclassified Bacteroidales, Unclassified Bacteria, Lactobacillus, 
Porphyromonas, Comamonas, Fusobacterium, Enterococcus, unclassified Carnobacteriaceae, 
Asticcacaulis 
Zhang et al.
75
 Chryseobacterium, Streptococcus, Enterococcus, Stenotrophomonas, Brevundimonas, Lactococcus, 
Sphingomonas, Prevotella, Sphingobacterium, Helcococcus, Leucobacter, Butyrivibrio, Atopostipes, 
Bosea, Alcaligenes, Ruminococcus, Facklamia, Actinomyces, Sphingobium, Trueperella, 
Pseudomonas, Enterobacter, Comamonas, Megasphera, Salinicoccus, Ochrobactrum, Lactobacillus, 
Mogibacterium, Peptococcus, Succiniclasticum, Myroides 
 189 
In dairy ruminant species other than cows, studies have been carried out almost exclusively for purposes of dairy 190 
production, and not for investigating mammary health or offspring health. Therefore, experimental design and 191 
sampling procedures may not be adequate for extracting information on the sensu stricto milk microbiota.
11
   192 
 193 
Origin of the milk microbiota: the endogenous route hypothesis 194 
Traditionally, it is believed that bacteria found in milk result from contamination by the external environment, the 195 
mammary gland skin, or the oral cavity of the offspring. However, several studies support the hypothesis that 196 
presence of bacteria in milk is not the mere result of an external colonization. It has been demonstrated that, 197 
adding to their different composition in terms of bacterial taxa, bacterial isolates present in the mammary gland 198 
are genotypically different from those found in skin, within the same host and the same bacterial species.
78
 199 
Therefore, the udder skin and teat canal cannot be considered as the sole contributors to shaping the milk 200 
microbiota.
65,79
 Adding to this, bacteria such as bifidobacteria are strictly anaerobic, making skin an unlikely 201 
source.
80
 These and other observations have led to consider the possibility of an endogenous route. In fact, 202 
ecological niches in the host microbiota do not constitute separate environments, but are rather a network of 203 
inter-related communities undergoing constant exchanges.
81
 Therefore, microorganisms from other anatomical 204 
locations may in some way make it to enter the mammary gland. More specifically, several authors described the 205 
existence of an entero-mammary pathway, based on the ability of some microbes to leave the intestinal lumen, 206 
travel through the mesenteric lymph nodes, and reach the mammary gland.
65,71,78,82–85
 207 
The suggestion of an endogenous origin of the milk microbiota has been corroborated by different studies carried 208 
out in mice.
71,86–89
 Although the mechanisms by which microbes get to cross the intestinal barrier and reach other 209 
body sites has not been completely clarified, it is likely that this may involve immune cells, especially Dendritic 210 
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Cells (DC).
71,82
 In fact, DCs are able to sample intestinal contents by opening the tight junctions among enterocytes, 211 
and reach the lumen with their dendrites without damaging the epithelial barrier integrity.
85,90
 As a result of this 212 
sampling ability, these cells can harbor live commensal bacteria, and carry them to the mesenteric lymph 213 
nodes.
91,92
 Once there, bacteria remain viable for up to several days, and have the chance to spread to other 214 
distant mucosal surfaces, including the lactating mammary gland, by means of the mucosal associated lymphoid 215 
system. In fact, during lactation, cells from gut-associated lymphoid tissue travel to the breast via the lymphatic 216 
and peripheral blood circulations. Donnet-Hughes et al. showed that, during lactation, human peripheral blood 217 
mononuclear cells and breast milk cells contain bacteria and their genetic material.
85
 In addition, the presence of 218 
viable lactic acid bacteria in the bloodstream of human subjects has been reported,
93–95
 further showing that some 219 
members of the intestinal microbiota may have a rather underrated ability to travel to distant extra-intestinal 220 
locations of their host in a viable form.
65
 The authors also showed an increase in bacterial translocation from the 221 
mouse intestine during pregnancy and lactation and the presence of bacterially loaded DCs in lactating breast 222 
tissue. 223 
 224 
Figure 3. The entero-mammary pathway hypothesis in ruminants and the mother-offspring microbial flow.  225 
 226 
The hormonal and physiological changes occurring during late pregnancy and lactation influence and condition 227 
permissivity of this bacterial transport.
66
 It is believed that, adding to the transport of viable members of the 228 
intestinal microbiota, this mechanism has the role of educating the offspring’s immune system to recognize 229 
molecular patterns associated to commensal microorganisms, in order to develop an appropriate response to 230 
them.
85
 This migration may occur either selectively, that is, certain strains may be recognized by immune cells and 231 
transported into milk, while others may not, or immune cells may take up all microorganisms, but only those able 232 
to escape killing would be transported to the mammary gland.
96
  233 
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A recent article by Young et al. reported the transfer of intestinal bacteria to the mammary gland in cows, 234 
supporting the existence of an endogenous entero-mammary pathway also in ruminants.
97
 The authors have 235 
investigated the microbial composition and diversity of feces, milk leukocytes and blood leukocytes in healthy 236 
lactating cows by pyrosequencing barcode-tagged 16S rDNA amplicons, demonstrating the shared presence of a 237 
small number of bacterial OTUs belonging to the Ruminococcus and Bifidobacterium genera and to the 238 
Peptostreptococcaceae family in all three samples from the same animals. In order to avoid external 239 
contamination and to prevent stretching or damaging of the teat canal, the authors used a catheter for collecting 240 
milk by gravity into a sterile container. The presence of these bacteria in the three environments supports the 241 
occurrence of a mechanism responsible for migration of some components of the intestinal microbiota to the 242 
mammary gland via circulating white blood cells. However, the cell types responsible for the trafficking of 243 
microbiota from the mesenteric lymph nodes to milk remain to be established. 244 
Further research will be needed to dissect the mechanisms by which intestinal bacteria are transported to the 245 
circulation and to the mammary gland of ruminants, as well as to understand the implications that this can have 246 
for the health of the lactating animal, her offspring, and the human consumer. The current knowledge on the 247 
entero-mammary pathway hypothesis in ruminants is outlined in Figure 3. 248 
 249 
Functions of the milk microbiota: lessons learned from human milk and the mouse model, 250 
and hints about its impact on the offspring ruminant health 251 
As stated above, most of the studies on the physiological milk microbiota of dairy ruminants have been carried out 252 
with a focus on how the microbial flora of milk evolves when it ceases to become a sensu stricto biological fluid to 253 
become a processed food or a dairy product.
11
 Therefore, most of the insights on the physiology of the mother’s 254 
milk microbiota and on its influences on the offspring development and health have been gathered from studies 255 
on humans and on the mouse model. 256 
The milk microbiota exerts many short and long term influences on both the mother and the offspring 257 
physiology.
71,72,98–101
 One of these is the transmission of microbes to the developing offspring gastrointestinal tract 258 
(Figure 3).
65,78,80,102–104
 The role of the milk microbiota as a “seed” for the developing intestinal microbiota is also 259 
evident in their close similarity; it is only after weaning that a significant diversification of the two communities 260 
takes place.
105
 As an example of the complex interaction among milk molecules, milk microbiota and offspring 261 
intestinal microbiota, it has been demonstrated that the abundant oligosaccharides present in human milk (HMOs, 262 
human milk oligosaccharides) are not digestible for the lactating infant. Instead, these are fermented by specific 263 
phylotypes of bifidobacteria and lactobacilli.
106–109
 In this way, HMOs provide a selective advantage to the milk and 264 
intestinal microbes that are able to metabolize them, and to thrive in the acidic environment generated by their 265 
digestion. In turn, this developing, selected microflora acts as a competitive “guard” to the blooming of adverse 266 
microbes. Although in lower concentration than human milk, bovine milk does also contain complex milk 267 
oligosaccharides analogous to HMOs, the bovine milk oligosaccharides (BMOs).
110–113
 However, the role that these 268 
BMOs play on the milk microbiota of the cow mammary gland and of the intestinal microbiota has not been 269 
investigated yet. 270 
Page 9 of 29 Molecular BioSystems
M
ol
ec
ul
ar
B
io
S
ys
te
m
s
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
09
 M
ay
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f L
iv
er
po
ol
 o
n 
09
/0
5/
20
16
 1
9:
57
:4
9.
 
View Article Online
DOI: 10.1039/C6MB00217J
10 
 
Milk influences other health promoting bacteria, including Lactobacillus, Bacteroides, and Clostridium species, that 271 
can influence mucin production, mucosal permeability, T-cell balance, and dampening of mucosal 272 
inflammation.
114–119
 Studies carried out in germ-free mice have revealed that the development of a fully functional 273 
immune system requires early life colonization.
120
 All this considered, milk bacteria can be crucial for programming 274 
the appropriate functionality of the immune system against food antigens, pathogens, and commensal bacteria. 275 
Therefore, the intestinal microbiota of the offspring, and the evolution of its immunity, are shaped by the 276 
“seeding” operated by the milk microbiota, deriving from the mother’s entero-mammary pathway, by the infant’s 277 
environment, and by the continuous crosstalk between the mother’s mammary gland and the suckling infant oral 278 
microbiota, with their synchronized development and evolution throughout lactation. In support of this latter 279 
observation, Cabrera-Rubio et al. have demonstrated that the milk microbiota of healthy women evolves along 280 
lactation, and undergoes a series of changes as lactation proceeds.
79
 281 
In ruminants, the role of the milk microbiota in shaping the intestinal microbiota of the newborn takes a further 282 
implication. In fact, these animals harbor an additional, very complex microbial community, that has the crucial 283 
role of carrying out plant digestion and converting otherwise non-digestible material into useful chemical 284 
compounds: the rumen microbiota.
121
 Microbial colonization of the rumen occurs almost immediately; bacteria 285 
with cellulolytic capabilities are already present in calves of 3-5 days of age, and are abundant in 2-3 week old 286 
calves.
122,123
 Recently, a study on ruminal bacterial communities has demonstrated that pre-ruminant calves 287 
harbor bacteria and functions that are present in mature animals.
124
 By using a pyrosequencing approach, Jami et 288 
al. have demonstrated that cellulolytic bacterial species are already present in the rumen of newborn calves as 289 
early as 1 day after birth, and at increasing abundance on the third day.
121
 This is reinforced by Fonty et al. and 290 
Minato et al., who isolated cellulolytic bacteria from the rumen in the first week after birth.
122,123
 Jami et al. 291 
demonstrated that establishment in the rumen of crucial bacterial species begins on the first day of life, when the 292 
animals are still being fed exclusively colostrum, that is, before the intake of plant material.
121
 This notion has also 293 
been advanced for microbial communities in the developing human infant’s intestinal microbiota.
125
 Although the 294 
authors do postulate that this primary bacterial community might be transmitted from the mother, they propose 295 
that this may occur via skin, the birth canal, or saliva.
126
 However, the role of the mother entero-mammary 296 
pathway in seeding the microbiota of the young ruminant might deserve further investigation. 297 
 298 
The milk microbiota and mammary gland infection 299 
Mastitis due to intramammary infection is a highly prevalent disease in dairy cows and it is arguably the most 300 
important one for the dairy industry worldwide, causing economic losses due to reduced milk production, 301 
discarded milk, lower probability of conception, premature culling, and treatment cost.
127
 The decrease in milk 302 
production per cow resulting from mastitis has been well-studied, and is estimated to impact on approximately 303 
15% of the milk production potential of the affected cow.
128
 Mastitis is also a serious animal welfare issue as it is 304 
associated with pain, reduced well-being and behavioural changes of the affected animals.
129
 Defined as 305 
inflammation of the mammary tissue, it can be characterized by the movement of leukocytes and serum proteins 306 
from the blood to the site of infection. As a consequence, mastitis is typically monitored by using as an indicator 307 
the number of cells present in a milliliter of milk, defined as the somatic cell count, although novel, potentially 308 
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highly sensitive, protein markers are emerging to aid its detection.
130–137
 Intramammary infection can be 309 
categorized into subclinical and clinical disease; the former is thought to be 3-40 times more prevalent than the 310 
latter and is defined as the presence of infection without clinical signs of local inflammation, whilst clinical mastitis 311 
involves an inflammatory response causing visibly abnormal milk, sometimes accompanied by swelling and/or 312 
redness of the mammary glands, and by an increase in the somatic cell count. 313 
Identification of the bacteria responsible for intramammary infection is an important component of eventual 314 
clinical resolution of the disease. Currently, bacterial culture is the gold standard method for identification of 315 
mastitis-causing microorganisms. However, limitations of classical bacterial culture, such as 48 hours to obtain 316 
results, or the fact that in approximately 25% of milk samples from clinical mastitis cases bacteria are not detected 317 
in conventional culture have spurred investigations of culture independent, molecular techniques for mastitis 318 
diagnosis.
138
 Methods such as real-time PCR
139
, multiplex PCR (mPCR)
140
, denaturing gradient gel electrophoresis 319 
(DGGE) PCR
141
, and PCR single-strand conformation polymorphism (SSCP)
142
 are now being used to identify 320 
bacterial DNA in milk samples. Molecular epidemiological studies have greatly contributed in advancing our 321 
knowledge of bovine mastitis, and have been extensively used for over two decades now.
143
 322 
Bhatt et al. performed metagenomic analysis of milk samples collected from Kankrej, Gir (Bos indicus) and 323 
crossbred cattle affected with subclinical mastitis using shotgun sequencing and 454 GS-FLX technology.
144
  Their 324 
metagenomic approach came to confirm culturing results, but was also able to produce a significant amount of 325 
additional information. A total of 56 different species with varying abundance were detected in the subclinically 326 
infected milk, together with several bacteriophages. The authors concluded that subclinical mastitis is a 327 
polymicrobial disease, a conclusion that was not well supported by their data mainly because samples from 328 
unaffected quarters were not obtained for comparison purposes.   329 
Oikonomou et al. used metagenomic pyrosequencing of bacterial 16S rDNA genes to investigate bacterial DNA 330 
diversity in milk samples of mastitic and healthy dairy cows and compared the results with those obtained by 331 
classical bacterial culture.
145
 One hundred and thirty-six milk samples were collected from cows showing signs of 332 
mastitis and used for microbiological culture. The mastitis pathogens identified by culture were generally among 333 
the most frequent organisms detected by pyrosequencing, and in some cases (Escherichia coli, Klebsiella spp. and 334 
Streptococcus uberis mastitis) the single most prevalent microorganism. Trueperella pyogenes sequences were the 335 
second most prevalent sequences in mastitis cases diagnosed as Trueperella pyogenes by culture, Streptococcus 336 
dysgalactiae sequences were the second most prevalent sequences in mastitis cases diagnosed as Streptococcus 337 
dysgalactiae by culture, and Staphyloccocus aureus sequences were the third most prevalent in mastitis cases 338 
diagnosed as Staphylococcus aureus by culture. In samples that were aerobic culture negative, pyrosequencing 339 
identified DNA of bacteria that are known to cause mastitis, DNA of bacteria that are known pathogens but have 340 
so far not been associated with mastitis, and DNA of bacteria that are currently not known to be pathogens. 341 
Additionally, a high number of anaerobic bacterial sequences (with sequences belonging to Fusobacterium 342 
necrophorum being highly prevalent) were identified in all mastitis cases, regardless of the culture-based diagnosis. 343 
On the other hand, Fusobacterium necrophorum sequences were practically absent in the 20 samples that were 344 
derived from healthy, low somatic cell count quarters, while Porphyromonas spp. sequences were detected but in 345 
low prevalence comparing to their prevalence in the mastitic samples. Therefore, a possible role of certain 346 
anaerobic bacteria as opportunistic pathogens was speculated. This study showed that the use of metagenomic 347 
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pyrosequencing of the 16S rDNA should be considered an important tool to advance our knowledge regarding the 348 
pathogenesis of bovine mastitis and could be developed as a diagnostic tool. However, being a cross-sectional 349 
prevalence study, it lacked the ability to show a proper time order to infer a cause and effect relationship. By using 350 
pyrosequencing of bacterial 16S rDNA genes, Kuehn et al. described the bacterial communities in culture negative 351 
mastitic milk samples, showing significant differences with healthy milk samples. Principal coordinates analysis 352 
suggested that non-clinical and clinical samples generally fell within separate clusters.
73
 In the study by Oikonomou 353 
et al., adding to bacterial genera present in all the samples obtained from healthy quarters (Faecalibacterium, 354 
unclassified Lachnospiraceae, Propionibacterium and Aeribacillus), Streptococcus uberis sequences were found in 355 
all groups of samples, with a lower prevalence in low somatic cell counts groups. This was considered unexpected 356 
by the authors as this bacterial species is generally recognized as a major mastitis pathogen. It was hypothesized 357 
that Streptococcus uberis may, although in small quantities, be part of the normal milk microbiota, and therefore 358 
clinical mastitis may in such cases be a dysbiosis, rather than a simple primary infection.
74
 In the Falentin et al. 359 
study, quarters with a mastitis history showed a higher proportion of the Bacilli class (Staphylococcus) and 360 
Chlamydiia class.
76
 Concerning dairy ruminant species other than cows, there are basically no -omics studies on 361 
how the milk microbiota changes in mastitis.  362 
From the studies carried out in women on the role of the milk microbiota in intramammary infections and mastitis, 363 
we may gather useful hints on the possible role of the intestinal microbiota as a reservoir for mastitis-causing 364 
bacteria. On the other hand, mechanisms such as nutrient competition, bacteriocins and antimicrobial molecules 365 
released by specific members of the community in milk may play a role in repressing the blooming of potential 366 
pathogens, and contrast intramammary infections.
100
 Hunt and coworkers have reported the host-dependence of 367 
the milk microbiota in women, and have suggested that its composition may play a role in determining whether 368 
they will suffer or not from mastitis.
72
 As reviewed above, HMOs have the ability to modulate the intestinal 369 
microbiota of the breastfed infant, and structurally analogous oligosaccharides, BMOs, are present in cow milk.
110–370 
113
 As such, it can be speculated that BMOs may also impact bacterial communities of the cow mammary gland.
66
 371 
Interestingly, HMOs fall within milk group categories that mirror blood group characteristics, and are under genetic 372 
control.
146
 It has been demonstrated that some strains of Staphylococcus, the leading cause of mastitis in women, 373 
bind only to selected HMO types.
147
 This would suggest that susceptibility to mastitis might be conditioned not 374 
only by the bacterial composition of milk or by exposure to specific pathogens, but also by the genetic makeup of 375 
the animal and the corresponding type of BMOs present in milk.
66
 376 
The existence of an entero-mammary pathway in ruminants
97
 (Figure 3) opens several interesting speculations 377 
concerning possible alternative ways to antibiotics for contrasting mastitis. In women, an effective mastitis 378 
treatment has been provided by the oral administration of probiotics, including Lactobacillus salivarius CECT5713 379 
and L. fermentum CECT5716.
88,89
 These impacted the milk microbiota by lowering the total bacterial count by 2 log 380 
and replacing mastitis-causing Staphylococcus species with Lactobacillus species. This was also shown to facilitate 381 
breastfeeding, leading to health benefits for both mother and infant. The possibility of influencing the milk 382 
microbiota through the oral administration of pre- or probiotics may open interesting perspectives in reducing the 383 
risk of mastitis in dairy cows.
148
 These examples emphasize the possible magnitude of the milk microbiota 384 
influence on dairy ruminant health, demanding future investigations. 385 
 386 
Page 12 of 29Molecular BioSystems
M
ol
ec
ul
ar
B
io
S
ys
te
m
s
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
09
 M
ay
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f L
iv
er
po
ol
 o
n 
09
/0
5/
20
16
 1
9:
57
:4
9.
 
View Article Online
DOI: 10.1039/C6MB00217J
13 
 
The impact of farming practices on the mother/offspring microbiota crosstalk, and the waste 387 
milk issue 388 
Current farming practices pose several hindrances to the finely evolved crosstalk between the mother and the 389 
offspring microbiota. In fact, although calf management procedures can slightly vary among commercial dairy 390 
farms,
149
 calves are removed from their dams after birth, and administered colostrum, pooled colostrum, or 391 
colostrum substitutes. Then, they are typically fed whole bulk tank milk, milk replacer, or a combination of them, 392 
together with a starter feed. Therefore, the mother/offspring microbiota axis, with its reciprocal crosstalk, is 393 
disrupted. In ruminants that are left with their mothers, the mother/offspring crosstalk may play a relevant role in 394 
evolution of both the mother’s milk and the intestinal microbiota of the offspring along lactation. 395 
In dairy calf management, attention should be paid to the quality of colostrum and milk that are administered in 396 
the farm, when considering that a healthy, well-balanced, microbiota-competent mother’s milk is crucial for a 397 
correct development of the offspring’s immune system. In fact, an imbalance in the intestinal microbiota is seen 398 
when calves are under stress conditions, such as in intensive rearing systems, with a reduction of Lactobacillus and 399 
Bifidobacterium species and an increase in pathobiont microorganisms. It is also interesting to notice that feeding 400 
whole milk to calves improved the lactic acid bacteria to coliforms ratio, further demonstrating the complex action 401 
exerted by milk on the intestinal microbiota.
150
 402 
Much care is given to providing clean and high quality colostrum to newborn calves within 6 hours from birth. 403 
However, numerous farms use unsaleable, waste milk, for post-colostrum calf feeding. Waste milk is represented 404 
by milk which cannot be sold for human consumption, and it is typically derived from cows with high somatic cell 405 
counts and from cows treated with antibiotics.
151
 Feeding waste milk to preweaned calves is a widespread 406 
phenomenon, if one considers that, in 2002, it was practiced in 87.2% of all US dairy farms.
152
 Although the use of 407 
waste milk is economically advantageous for the farmer, and it is generally believed to be a safe and better 408 
alternative to milk replacers, especially after pasteurization, it can raise some concerns. In fact, waste milk can be 409 
heavily unbalanced in terms of milk microbiota, be contaminated with potentially harmful pathogens,
153
 or contain 410 
antibiotic residues, with possible consequences on the future animal well-being.
154
 411 
These issues have been examined by different research groups. Edrington et al. evaluated the effect of feeding 412 
waste milk on the bacterial diversity of the dairy calf fecal microbiota.
149
 The authors applied 16S rDNA bacterial 413 
tag-encoded FLX amplicon pyrosequencing to fecal samples from one week to six month old dairy calves fed 414 
pasteurized or nonpasteurized waste milk. As a result, bacterial diversity in terms of total number of different 415 
species was higher in calves fed pasteurized waste milk, and increased with age in both groups. Concerning specific 416 
microorganisms, Salmonella was detected in calves fed unpasteurized waste milk, and Treponema, an important 417 
beneficial bacterium in rumen, was higher in the pasteurized waste milk group, becoming higher with age in the 418 
same group. The consistent detection of Salmonella only in young calves fed unpasteurized waste milk was an 419 
important finding related to this practice. In conclusion, therefore, pasteurization of waste milk was advised. The 420 
impact of feeding bulk milk or waste milk on calf performance and health was evaluated also by Aust and 421 
coworkers. According to these authors as well, pasteurized waste milk can be  considered an acceptable feed.
155
 422 
A more significant problem concerning the use of waste milk, however, may be represented by presence of 423 
antimicrobial residues, and the potential enrichment in the antibiotic resistance gene (ARG) pool available for 424 
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transfer to pathogens, the “resistome”.
156
 In addition, continuous antibiotic pressure may increase opportunities 425 
for horizontal ARG transfer.
157–159
 It should also be considered that the intestinal microbiota resistome is largely 426 
studied with culture-based or PCR-based experiments, with a consequent underestimation of novel resistance 427 
genes.
160–163
 428 
An important aspect that needs to be taken into account when examining literature data is the administration 429 
route. In this respect, mouse models can provide useful indications on the impact of antibiotics fed to young calves 430 
through waste milk consumption, since in the case of infant mice antibiotics are administered through the 431 
mother’s milk.
154,164
 In support of this observation, significant differences were observed upon oral versus 432 
intravenous administration of ampicillin and tetracycline. Oral administration resulted in a 4-log increase in 433 
ampicillin and 2-fold increase in tetracycline resistance gene copy number over intravenous administration. This is 434 
also probably due to the fact that intravenously administered ampicillin is cleared through urine and does not 435 
interact with the gut microbiota.
165
 436 
Adding to enrichment and selection of ARGs, antibiotics can affect specific phylogenetic subgroups of the intestinal 437 
microbiota. Preterm human infants treated with different antibiotics have an increased load of potentially 438 
pathogenic (pathobionts) Enterobacteriaceae, and a lower number of Bifidobacteriaceae, Bacilli, and 439 
Lactobacillales, that are connected to a healthy microbiota.
166–168
 In mice exposed to subtherapeutic doses of 440 
antibiotics in drinking water, there was a significant decrease in the ratio of Bacteroides to Firmicutes, although 441 
this may depend on the specific spectra of antibiotics used.
164
 In another study, administration of cefoperazone 442 
was associated to a loss in microbial diversity without recovery at six weeks.
169
 Therefore, in mice, even low 443 
antibiotic dosages have long-term consequences on microorganisms associated with healthy microbiota, including 444 
Lactobacillus spp., Bifidobacteriaceae (lowered) and Enterobacteriaceae (increased).
164,167
 445 
 Limited information is currently available on the impact of drug residues on the microbiota using in vivo natural 446 
models. Van Vleck Pereira et al. evaluated the effect on the calf fecal microbiota of feeding raw milk spiked with 447 
antibiotic concentrations below the safe levels limit established by the Federal Department of Agriculture (FDA).
170
  448 
Sequencing of the microbial 16S rRNA genes was conducted using the Illumina MiSeq on calf feces collected along 449 
six weeks of age. The study demonstrated that the presence of drug residues in the milk affects the composition of 450 
the microbial population in the feces. In fact, the weekly fecal microbial profile of the two calf groups was easily 451 
discriminated at the genus level, although no significant differences were seen for higher taxonomic levels. The 452 
authors postulated that even minimal antibiotic concentrations may have a selective impact on the competition 453 
among microbes, by influencing the final balance between sensitive and resistant microbial populations. That is, 454 
residues can exert a selective pressure on immature microbiota that have none or very low resistance to 455 
colonization by foreign microbes, resulting in an abrupt transition to a microbial profile that is most commonly 456 
found in older preweaned calves. In fact, when microbes are exposed to sub-minimal inhibitory concentrations of 457 
antibiotics, these will not kill all susceptible bacteria, but will impair their growth, providing a selective advantage 458 
to microbes that carry ARG with a low fitness costs, contributing to their persistence even when the antibiotic is 459 
removed.
171
 460 
The occurrence of changes in the fecal microbiota of young calves upon parenteral antibiotic administrations was 461 
also seen by Oultram et al. in a preliminary study.
172
 One week post treatment the groups showed the greatest 462 
difference in the fecal microbiota composition, while two weeks post-treatment they became more similar, 463 
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showing a recovery of microbial diversity in the treated group. Lactobacillus species were the most affected by 464 
antibiosis. Further studies will be needed, and are advised, to clarify the impact of antibiotic residues in milk on the 465 
correct maturation and health of the dairy ruminant microbiota. 466 
Another farming practice potentially interfering with the milk microbiota balance is represented by the 467 
intramammary antibiotic therapy administered to cows at dry-off or during lactation. In fact, many dairy herds are 468 
routinely treated in every quarter with antibiotic at drying off. This is defined as “blanket” approach, and is 469 
considered more effective than selective treatment in preventing new infections early in the dry period, without 470 
requiring laboratory screening procedures to decide which cows and quarters to treat. Lactation intramammary 471 
antibiotic tubes are the most common treatment for mild and moderate cases of mastitis, and are usually given 472 
without knowing the type of bacteria that is causing the infection.
173,174
 However, when subclinical mastitis in a 473 
herd is very low level (every cow has SCC below 100,000 cells/ml), intramammary antibiotic administration only to 474 
selected higher risk cows is considered appropriate by some dairy farmers and veterinarians. Because of concerns 475 
about selection for antimicrobial resistance, the blanket approach has not been implemented in the Nordic 476 
European countries for decades and it is increasingly abandoned in The Netherlands. The impact of this practice on 477 
the physiological milk microbiota and on the potential selection for ARG may deserve further investigation.  478 
 479 
Raw milk microbial ecology and its impact on dairy products 480 
Being a rich and nutritious fluid, milk supports the growth of many microorganisms. Therefore, adding to its 481 
endogenous microbiota, once milked it is rapidly colonized by a variety of other microbes coming from the teat 482 
canal, udder skin, milking machine, containers and tanks used for its storage, reflecting also the farm and the 483 
pasture environment. Adding to the contribution that these can exert on milk fermentation by transforming 484 
lactose in lactate, they can bring about a variety of attributes that impact on the sensory and textural 485 
characteristics of the dairy products derived from it.
175
 Furthermore, contamination with, and subsequent growth 486 
in milk of potentially pathogenic bacteria (or with toxins produced by them) can have implications for human 487 
health and is therefore a relevant issue to consider. And, it is also important to assess how the composition of the 488 
microbiota evolves in raw milk during milking, transport, storage, and dairy processing, and how it impacts on the 489 
composition and quality of dairy products (Table 3). 490 
Table 3. Sources and impact of exogenous microorganisms found in raw milk.
11
 491 
Sources Impact 
 Food Technology Health Promotion Spoilage Human illness 
Udder and teat 
Hides 
Feces 
Housing 
Bedding 
Feed/Pasture 
Air 
Water 
Lactococcus 
Lactobacillus 
Streptococcus 
Leuconostoc 
Enterococcus 
Propionibacterium 
Lactococcus 
Lactobacillus 
Streptococcus 
Leuconostoc 
Enterococcus 
Yeast species 
Pseudomonas 
Acinetobacter 
Chrysebacterium 
Clostridium 
Phages 
Listeria 
Staphylococcus 
Escherichia 
Campylobacter 
Mycobacterium 
Fungi - aflatoxins 
 
 492 
These studies have been recently covered in a complete and extensive review by Quigley and coworkers, and we 493 
refer the readers to their work for a detailed description of the recent literature on this subject.
11
 In their review, 494 
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the authors describe the current knowledge on the microorganisms that can be found in raw milk of the main dairy 495 
ruminant species. 496 
 497 
Conclusion 498 
The tremendous evolution of molecular and -omics technologies has enabled numerous breakthroughs in the 499 
study of microbial communities, making us aware of the varied and complex assortments of microbes that inhabit 500 
living animals, and of the reciprocal interactions that these entertain among themselves and with their hosts. 501 
Following the unexpected acknowledgement that even the healthy mammary gland, and the milk contained within 502 
it, are colonized by a variety of microbes, -omics approaches have already been used to enable their 503 
characterization in humans, as well as to understand the role they play in both the mother and the offspring 504 
health. Following the studies on raw milk microbial ecology, -omics approaches are now beginning to be applied 505 
also to the sensu stricto milk microbiota of dairy ruminants. As a result, its relevant interactions with the 506 
physiology and health of the lactating dam and the suckling offspring are becoming more and more evident. When 507 
considering the significant economical implications that this can have for dairy ruminant farming, the application 508 
of -omics sciences to the milk microbiota is expected to improve our understanding of open questions and 509 
challenges such as the etiology and dynamics of sub-clinical and culture-negative mastitis, the impact of farming 510 
management decisions on the mammary gland health and offspring health, the role of the intestine as a mastitis 511 
pathogen reservoir, the development of novel strategies for preventing and contrasting mastitis management, and 512 
the control of antibiotic resistance. 513 
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